Some biomedical startups that were previously months or years away from putting initial products on the market are using their technology to combat the new coronavirus, thanks to emergency-use authorizations.
U.S. Food and Drug Administration officials have exercised their authority to allow unapproved tests, drugs and other medical products to be used against the pandemic. Even though several emergency authorizations have gone to corporations, many small businesses with few or no FDA-approved products have received them as...
"emergency" - Google News
September 24, 2020 at 05:00PM
https://ift.tt/2FNyhBL
Biomedical Startups Secure Emergency Authorizations for Covid-19 Fight - The Wall Street Journal
"emergency" - Google News
https://ift.tt/2VVGGYQ
https://ift.tt/3d7MC6X
emergency
Bagikan Berita Ini
0 Response to "Biomedical Startups Secure Emergency Authorizations for Covid-19 Fight - The Wall Street Journal"
Post a Comment